The groundbreaking therapy of tirzepatide peptide represents a major advance in the management of type 2 diabetes. Different to existing drugs, tirzepatide impacts dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide066066.activoblog.com/54171358/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment